STERIS plc Quarterly Nonoperating Income (Expense) in USD from Q2 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
STERIS plc quarterly/annual Nonoperating Income (Expense) history and growth rate from Q2 2018 to Q3 2024.
  • STERIS plc Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$24.8M, a 30.6% increase year-over-year.
  • STERIS plc Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was -$102M, a 20.2% increase year-over-year.
  • STERIS plc annual Nonoperating Income (Expense) for 2023 was -$133M, a 20.3% decline from 2022.
  • STERIS plc annual Nonoperating Income (Expense) for 2022 was -$111M, a 0.16% increase from 2021.
  • STERIS plc annual Nonoperating Income (Expense) for 2021 was -$111M, a 260% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$102M -$24.8M +$10.9M +30.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$113M -$10.3M +$20.7M +66.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$133M -$29.8M +$519K +1.71% Jan 1, 2024 Mar 31, 2024 10-K 2024-05-29
Q4 2023 -$134M -$36.9M -$6.4M -21% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-08
Q3 2023 -$127M -$35.7M -$9.05M -34% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$118M -$31M -$7.54M -32.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$111M -$30.3M -$9.99M -49.2% Jan 1, 2023 Mar 31, 2023 10-K 2024-05-29
Q4 2022 -$101M -$30.5M -$9.94M -48.4% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-08
Q3 2022 -$90.9M -$26.6M +$249K +0.93% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$91.2M -$23.4M +$19.9M +45.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$111M -$20.3M -$11.7M -137% Jan 1, 2022 Mar 31, 2022 10-K 2024-05-29
Q4 2021 -$99.3M -$20.5M -$12.9M -170% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-08
Q3 2021 -$86.4M -$26.9M -$19.4M -260% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$66.9M -$43.3M -$36.1M -501% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$30.8M -$8.56M +$1.2M +12.3% Jan 1, 2021 Mar 31, 2021 10-K 2023-05-26
Q4 2020 -$32M -$7.6M +$835K +9.9% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-09
Q3 2020 -$32.9M -$7.48M +$1.95M +20.7% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$34.8M -$7.2M +$3.48M +32.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 -$38.3M -$9.75M -$2.28M -30.4% Jan 1, 2020 Mar 31, 2020 10-K 2022-05-31
Q4 2019 -$36M -$8.44M +$3.39M +28.7% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-09
Q3 2019 -$39.4M -$9.43M +$1.89M +16.7% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 -$41.3M -$10.7M +$695K +6.11% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 -$42M -$7.48M Jan 1, 2019 Mar 31, 2019 10-K 2021-05-28
Q4 2018 -$11.8M Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-10
Q3 2018 -$11.3M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$11.4M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.